BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for PIERRE FABRE PHARMACEUTICALS INC. · Pharmaceutical manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Jan 16, 2026

Lobbying activity 1

Pharmacy

Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.